Stockscreener 앱 받기
2.09
2.79%
-0.06
시간 외 거래:
2.10
0.01
+0.48%
전일 마감가:
$2.15
열려 있는:
$2.13
하루 거래량:
18,705
Relative Volume:
0.84
시가총액:
$9.56M
수익:
$1.79M
순이익/손실:
$-64.45M
주가수익비율:
-1.2744
EPS:
-1.64
순현금흐름:
$-53.32M
1주 성능:
-6.70%
1개월 성능:
-8.33%
6개월 성능:
-45.29%
1년 성능:
-48.07%
1일 변동 폭
$2.0888
$2.2675
1주일 범위
$2.0888
$2.47
52주 변동 폭
$1.5201
$7.43
센티 바이오사이언시스 Stock (SNTI) Company Profile
명칭
Senti Biosciences Inc
전화
(650) 382-3281
주소
2 CORPORATE DRIVE, FIRST FLOOR, SOUTH SAN FRANCISCO
SNTI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| SNTI | 2.09 | 9.56M | 1.79M | -64.45M | -53.32M | -1.64 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
센티 바이오사이언시스 Stock (SNTI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-10-07 | 개시 | Morgan Stanley | Equal-Weight |
센티 바이오사이언시스 주식(SNTI)의 최신 뉴스
Senti Biosciences Faces Financial Challenges Amid Strategic Focus - TipRanks
Senti Biosciences Inc (SNTI) Quarterly 10-Q Report - Quartzy
Senti Bio Announces Third Quarter 2024 Results and Recent Pipeline and Corporate Highlights - The Manila Times
Senti Bio Reports $28.9M Q3 Loss, Advances Cancer Drug Trial Amid Cost Cuts | SNTI Stock News - StockTitan
NK Cell Therapy Clinical Trial Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Malaysian Reserve
Senti Biosciences, Inc. (NASDAQ:SNTI) Short Interest Update - MarketBeat
Senti Biosciences faces nasdaq delisting over audit rule By Investing.com - Investing.com Australia
Senti Biosciences faces nasdaq delisting over audit rule - Investing.com India
Senti Biosciences (NASDAQ:SNTI) Trading 7.8% HigherHere's Why - MarketBeat
Senti Biosciences, Inc. Enters into A Sublease Agreement, or the Sublease, with BKPBIOTECH, Inc. and Jlsa2 Therapeutics, Inc - Marketscreener.com
Institutional owners may take dramatic actions as Semler Scientific, Inc.'s (NASDAQ:SMLR) recent 10% drop adds to one-year losses - Simply Wall St
Biotech Soars On Material Transfer Agreement - Invezz
Nasdaq Composite (NASX) QuotePress Release - The Globe and Mail
Sensata Technologies Holding plc (NYSE:ST) Stake Decreased by Shapiro Capital Management LLC - Defense World
Federated Hermes Inc. Increases Holdings in Sensata Technologies Holding plc (NYSE:ST) - Defense World
2,100 Shares in Silicon Laboratories Inc. (NASDAQ:SLAB) Bought by MQS Management LLC - Defense World
Granite Investment Partners LLC Increases Stock Holdings in Silicon Laboratories Inc. (NASDAQ:SLAB) - Defense World
Moors & Cabot Inc. Acquires 8,900 Shares of Sensata Technologies Holding plc (NYSE:ST) - Defense World
Sensata Technologies (NYSE:ST) Releases Q3 2024 Earnings Guidance - Defense World
Ratios Reveal: Breaking Down SenesTech Inc (SNES)’s Financial Health - The Dwinnex
Critical Analysis: UL Solutions (NYSE:ULS) & NeoGenomics (NASDAQ:NEO) - Defense World
Daiwa Securities Group Inc. Purchases Shares of 545 Silicon Laboratories Inc. (NASDAQ:SLAB) - Defense World
Semler Scientific Inc (SMLR) Shares Gap Down to $24.43 on Sep 18 - GuruFocus.com
SanBio’s Q2 Financials and Regenerative Medicine Push - TipRanks
After-hours movers: Intuitive Machines, Casella Waste Systems, Galmed Pharma, Edgewise Therapeutics - Investing.com Australia
Headlands Technologies LLC Sells 3,234 Shares of Sensata Technologies Holding plc (NYSE:ST) - Defense World
Daiwa Securities Group Inc. Has $786,000 Stock Position in Sensata Technologies Holding plc (NYSE:ST) - Defense World
Federated Hermes Inc. Raises Stake in Silicon Laboratories Inc. (NASDAQ:SLAB) - MarketBeat
SNTI Stock Earnings: Senti Biosciences Reported Results for Q2 2024 - MSN
Senti Bio to Participate in Upcoming Investor Conferences - Yahoo Finance UK
Senti Biosciences (NASDAQ:SNTI) Trading Up 5.2% - MarketBeat
Biopharma Layoff Tracker 2024: Lykos, Galera, Grail and More Cut Staff - BioSpace
SNTISenti Biosciences, Inc. Latest Stock News & Market Updates - StockTitan
Senti Bio Announces Second Quarter 2024 Results and Reviews Recent Corporate and Pipeline Highlights - BioSpace
Intel Dumps All Of Its Shares In Arm Holdings, Still Retains Exposure To Astera Labs, Joby Aviation, MariaDB, And Senti Biosciences - Wccftech
Titan Pharmaceuticals (NASDAQ:TTNP) vs. Senti Biosciences (NASDAQ:SNTI) Critical Contrast - Defense World
A Deep Dive into Senti Biosciences Inc. (SNTI) Stock Performance - The InvestChronicle
Financial Health Report: Senti Biosciences Inc. (SNTI)’s Ratios Tell a Tale - The Dwinnex
Senti Bio Announces Execution of Grant Award from California Institute for Regenerative Medicines (CIRM) for Clinical Development of SENTI-202 - ForexTV.com
Senti Bio announces execution of grant award from CIRM for developing SENTI-202 - TipRanks
Senti Biosciences announces 1-for-10 reverse stock split - Investing.com India
Senti Biosciences announces 1-for-10 reverse stock split By Investing.com - Investing.com Canada
Senti Biosciences Inc. (SNTI)’s highs and lows: A closer look at its stock price fluctuations - US Post News
Senti Biosciences amends equity facility agreement - Investing.com
Senti Bio executes reverse stock split to meet Nasdaq requirements - Investing.com
Senti Biosciences to effect 1-for-10 reverse stock split for Nasdaq compliance - Seeking Alpha
Senti Bio Announces Reverse Stock Split - Yahoo Finance
Senti Biosciences (NASDAQ:SNTI) Trading Down 2.1% - Defense World
There is no way Senti Biosciences Inc. (SNTI) can keep these numbers up - SETE News
Examining Senti Biosciences Inc. (SNTI) stock is warranted - US Post News
Daily Market Movement: Senti Biosciences Inc. (SNTI) Sees a -20.51 Decrease, Closing at 0.31 – DWinneX - The Dwinnex
센티 바이오사이언시스 (SNTI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.66%
1.11%
자본화:
|
볼륨(24시간):